265 related articles for article (PubMed ID: 21813638)
1. Roles of FGF19 in liver metabolism.
Kir S; Kliewer SA; Mangelsdorf DJ
Cold Spring Harb Symp Quant Biol; 2011; 76():139-44. PubMed ID: 21813638
[TBL] [Abstract][Full Text] [Related]
2. Role of fibroblast growth factor 19 in the control of glucose homeostasis.
Schaap FG
Curr Opin Clin Nutr Metab Care; 2012 Jul; 15(4):386-91. PubMed ID: 22617565
[TBL] [Abstract][Full Text] [Related]
3. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.
Schreuder TC; Marsman HA; Lenicek M; van Werven JR; Nederveen AJ; Jansen PL; Schaap FG
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G440-5. PubMed ID: 20093562
[TBL] [Abstract][Full Text] [Related]
4. The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism.
Cariello M; Piglionica M; Gadaleta RM; Moschetta A
Handb Exp Pharmacol; 2019; 256():73-93. PubMed ID: 31123830
[TBL] [Abstract][Full Text] [Related]
5. The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.
Zweers SJ; Booij KA; Komuta M; Roskams T; Gouma DJ; Jansen PL; Schaap FG
Hepatology; 2012 Feb; 55(2):575-83. PubMed ID: 21953282
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys.
Pai R; French D; Ma N; Hotzel K; Plise E; Salphati L; Setchell KD; Ware J; Lauriault V; Schutt L; Hartley D; Dambach D
Toxicol Sci; 2012 Apr; 126(2):446-56. PubMed ID: 22268002
[TBL] [Abstract][Full Text] [Related]
7. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.
Kir S; Beddow SA; Samuel VT; Miller P; Previs SF; Suino-Powell K; Xu HE; Shulman GI; Kliewer SA; Mangelsdorf DJ
Science; 2011 Mar; 331(6024):1621-4. PubMed ID: 21436455
[TBL] [Abstract][Full Text] [Related]
8. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
Kliewer SA; Mangelsdorf DJ
Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
[TBL] [Abstract][Full Text] [Related]
9. The Role of FGF19 and MALRD1 in Enterohepatic Bile Acid Signaling.
Wang LX; Frey MR; Kohli R
Front Endocrinol (Lausanne); 2021; 12():799648. PubMed ID: 35116006
[TBL] [Abstract][Full Text] [Related]
10. Developmental regulation of the intestinal FGF19 system in domestic pigs.
Gavaldà-Navarro A; Pastor JJ; Mereu A; Villarroya F; Ipharraguerre IR
Am J Physiol Gastrointest Liver Physiol; 2018 Jun; 314(6):G647-G654. PubMed ID: 29446652
[TBL] [Abstract][Full Text] [Related]
11. TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk.
Bhat N; Esteghamat F; Chaube BK; Gunawardhana K; Mani M; Thames C; Jain D; Ginsberg HN; Fernandes-Hernando C; Mani A
FASEB J; 2022 Mar; 36(3):e22185. PubMed ID: 35133032
[TBL] [Abstract][Full Text] [Related]
12. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.
Alvarez-Sola G; Uriarte I; Latasa MU; Fernandez-Barrena MG; Urtasun R; Elizalde M; Barcena-Varela M; Jiménez M; Chang HC; Barbero R; Catalán V; Rodríguez A; Frühbeck G; Gallego-Escuredo JM; Gavaldà-Navarro A; Villarroya F; Rodriguez-Ortigosa CM; Corrales FJ; Prieto J; Berraondo P; Berasain C; Avila MA
Gut; 2017 Oct; 66(10):1818-1828. PubMed ID: 28119353
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic utilities of fibroblast growth factor 19.
Wu X; Li Y
Expert Opin Ther Targets; 2011 Nov; 15(11):1307-16. PubMed ID: 21961833
[TBL] [Abstract][Full Text] [Related]
15. The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19.
Piglionica M; Cariello M; Moschetta A
Curr Opin Pharmacol; 2018 Dec; 43():93-98. PubMed ID: 30223181
[TBL] [Abstract][Full Text] [Related]
16. Mini-review: endocrine actions of fibroblast growth factor 19.
Jones S
Mol Pharm; 2008; 5(1):42-8. PubMed ID: 18179175
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver.
Cicione C; Degirolamo C; Moschetta A
Hepatology; 2012 Dec; 56(6):2404-11. PubMed ID: 22753116
[TBL] [Abstract][Full Text] [Related]
18. Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations.
Mellor HR
Liver Int; 2014 Jul; 34(6):e1-9. PubMed ID: 24393342
[TBL] [Abstract][Full Text] [Related]
19. A nontumorigenic variant of FGF19 treats cholestatic liver diseases.
Luo J; Ko B; Elliott M; Zhou M; Lindhout DA; Phung V; To C; Learned RM; Tian H; DePaoli AM; Ling L
Sci Transl Med; 2014 Jul; 6(247):247ra100. PubMed ID: 25080475
[TBL] [Abstract][Full Text] [Related]
20. Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.
Liu WY; Xie DM; Zhu GQ; Huang GQ; Lin YQ; Wang LR; Shi KQ; Hu B; Braddock M; Chen YP; Zheng MH
Expert Opin Ther Targets; 2015 May; 19(5):675-85. PubMed ID: 25547779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
